Business Wire
03 Feb 2026, 19:32 UTC · 33w ago
Verdict
Headline takes no side. We score EXAS +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 85% of ticker scores this week
Which stocks this story touches
More positive than 85% of ticker scores this week
The passage of federal legislation enabling Medicare coverage for MCED tests creates a significant growth pathway for the company's diagnostics.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+2.4%
Price agrees with the score
$104.91 vs $102.50 close before publication (Feb 2) · not market-adjusted
EXAS chart →